159 related articles for article (PubMed ID: 28806355)
1. Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.
Hussain I; Mach O; Habib A; Bhatti Z; Suhag Z; Oberste MS; Weldon WC; Sutter RW; Soofi SB; Bhutta ZA
Pediatr Infect Dis J; 2017 Sep; 36(9):e230-e236. PubMed ID: 28806355
[TBL] [Abstract][Full Text] [Related]
2. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
Hussain I; Mach O; Hamid NA; Bhatti ZS; Moore DD; Oberste MS; Khan S; Khan H; Weldon WC; Sutter RW; Bhutta ZA; Soofi SB
Vaccine; 2018 Apr; 36(15):1921-1924. PubMed ID: 29510918
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
6. Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa.
Guindo O; Mach O; Doumbia S; Ekra DK; Beavogui AH; Weldon WC; Oberste MS; Sutter RW
Vaccine; 2018 Feb; 36(8):1027-1031. PubMed ID: 29358054
[TBL] [Abstract][Full Text] [Related]
7. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus antibody levels and lameness among individuals in three regions of Ghana.
Opare JKL; Odoom JK; Akweongo P; Afari EA; Pappoe M
Hum Vaccin Immunother; 2019; 15(9):2050-2059. PubMed ID: 31265356
[No Abstract] [Full Text] [Related]
9. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
Opare JK; Akweongo P; Afari EA; Odoom JK
Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
[TBL] [Abstract][Full Text] [Related]
10. Progress Toward Poliomyelitis Eradication--Pakistan, January 2014-September 2015.
Farag NH; Wadood MZ; Safdar RM; Ahmed N; Hamdi S; Tangermann RH; Ehrhardt D
MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(45):1271-5. PubMed ID: 26584026
[TBL] [Abstract][Full Text] [Related]
11. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional Serologic Assessment of Immunity to Poliovirus in Differential Risk Areas of India: India Seroprevalence Survey - 2014.
Ahmad M; Bahl S; Kunwar A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S14-S19. PubMed ID: 27771634
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
[TBL] [Abstract][Full Text] [Related]
14. Progress Toward Poliomyelitis Eradication - Pakistan, January 2022-June 2023.
Mbaeyi C; Baig S; Safdar RM; Khan Z; Young H; Jorba J; Wadood ZM; Jafari H; Alam MM; Franka R
MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(33):880-885. PubMed ID: 37590173
[TBL] [Abstract][Full Text] [Related]
15. Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.
Hsu CH; Wannemuehler KA; Soofi S; Mashal M; Hussain I; Bhutta ZA; McDuffie L; Weldon W; Farag NH
Vaccine; 2019 Mar; 37(12):1577-1583. PubMed ID: 30782488
[TBL] [Abstract][Full Text] [Related]
16. Progress Toward Poliomyelitis Eradication - Pakistan, January 2019-September 2020.
Hsu CH; Rehman MS; Bullard K; Jorba J; Kader M; Young H; Safdar M; Jafari HS; Ehrhardt D
MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(46):1748-1752. PubMed ID: 33211676
[TBL] [Abstract][Full Text] [Related]
17. Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.
Hussain I; Umer M; Khan A; Sajid M; Ahmed I; Begum K; Iqbal J; Alam MM; Safdar RM; Baig S; Voorman A; Partridge J; Soofi S
Front Public Health; 2024; 12():1384410. PubMed ID: 38601488
[TBL] [Abstract][Full Text] [Related]
18. Survey of poliovirus antibodies in Kano, Northern Nigeria.
Iliyasu Z; Nwaze E; Verma H; Mustapha AO; Weldegebriel G; Gasasira A; Wannemuehler KA; Pallansch MA; Gajida AU; Pate M; Sutter RW
Vaccine; 2014 Mar; 32(12):1414-20. PubMed ID: 24041545
[TBL] [Abstract][Full Text] [Related]
19. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.
Alleman MM; Wannemuehler KA; Weldon WC; Kabuayi JP; Ekofo F; Edidi S; Mulumba A; Mbule A; Ntumbannji RN; Coulibaly T; Abiola N; Mpingulu M; Sidibe K; Oberste MS
J Infect Dis; 2014 Nov; 210 Suppl 1():S62-73. PubMed ID: 25316879
[TBL] [Abstract][Full Text] [Related]
20. Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014.
Craig KT; Verma H; Iliyasu Z; Mkanda P; Touray K; Johnson T; Walla A; Banda R; Tegegne SG; Yehualashet YG; Abba B; Ahmad-Shehu A; Takane M; Sutter RW; Nsubuga P; Muhammad AJ; Vaz RG
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S124-30. PubMed ID: 26908720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
